Improving targeting and yield of AAV by capsid and cell engineering 2021 (English)In: Human Gene Therapy, ISSN 1043-0342, E-ISSN 1557-7422, Vol. 32, no 19-20, p. A119-A120Article in journal, Meeting abstract (Other academic) Published

Place, publisher, year, edition, pages

MARY ANN LIEBERT, INC , 2021. Vol. 32, no 19-20, p. A119-A120

National Category

Genetics and Genomics Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Identifiers

URN: urn:nbn:se:kth:diva-315551ISI: 000811305600350OAI: oai:DiVA.org:kth-315551DiVA, id: diva2:1682027

Note

QC 20220708

Available from: 2022-07-08 Created: 2022-07-08 Last updated: 2025-02-01Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Malm, MagdalenaVolk, Anna-LuisaKarlander, MaximilianLundqvist, MagnusWistbacka, NumRazavi, RoniaPintar, AntonThorell, HannesChotteau, VéroniqueRockberg, Johan

Search in DiVA

By author/editor

Malm, MagdalenaVolk, Anna-LuisaKarlander, MaximilianLundqvist, MagnusWistbacka, NumRazavi, RoniaPintar, AntonThorell, HannesChotteau, VéroniqueRockberg, Johan

By organisation

Protein TechnologyProtein ScienceIndustrial Biotechnology

In the same journal

Human Gene Therapy

On the subject

Genetics and GenomicsMedical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle ScholarTotal: 568 hits